Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection-Reference-Cited by-同舟云学术

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection

Published:2022-05-28 Issue:6 Volume:42 Page:525-531
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Megna Matteo^ORCID,Patruno Cataldo,Bongiorno Maria Rita,Gambardella Alessio,Guarneri Claudio,Romita Paolo,Raimondo Annunziata,Loconsole Francesco,Fabbrocini Gabriella

Funder

Università degli Studi di Napoli Federico II

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01163-5.pdf

Reference47 articles.

1. Menter A, Strober BE, Kaplan DH, Kivelevitch D, Prater EF, Stoff B, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80:1029–72. https://doi.org/10.1016/j.jaad.2018.11.057.

2. Nast A, Altenburg A, Augustin M, Boehncke WH, Härle P, Klaus J, et al. German S3 guideline on the treatment of psoriasis vulgaris, adapted from EuroGuiDerm. Part 1: treatment goals and treatment recommendations. J Dtsch Dermatol Ges. 2021;19:934–150. https://doi.org/10.1111/ddg.14508.

3. Gisondi P, Altomare G, Ayala F, Bardazzi F, Bianchi L, Chiricozzi A, et al. Italian guidelines on the systemic treatments of moderate-to-severe plaque psoriasis. J Eur Acad Dermatol Venereol. 2017;31:774–90. https://doi.org/10.1111/jdv.14114.

4. Gisondi P, Talamonti M, Chiricozzi A, Piaserico S, Amerio P, Balato A, et al. Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations. Dermatol Ther. 2021;11:235–52. https://doi.org/10.1007/s13555-020-00475-8.

5. Megna M, Balato A, Napolitano M, Gallo L, Caso F, Costa L, et al. Psoriatic disease treatment nowadays: unmet needs among the “jungle of biologic drugs and small molecules.” Clin Rheumatol. 2018;37:1739–41. https://doi.org/10.1007/s10067-018-4090-6.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B reactivation in PsA patients: an SLR and meta-analysis for IL-17, IL-23 and JAK inhibitors;Rheumatology;2024-08-17

2. Management of Psoriasis Patients with Serious Infectious Diseases;Advances in Therapy;2024-05-06

3. Choosing the right biologic treatment for moderate-to-severe plaque psoriasis: the impact of comorbidities;Expert Review of Clinical Pharmacology;2024-04-02

4. Hepatitis B virus reactivation in patients treated with monoclonal antibodies;World Journal of Virology;2024-03-25

5. The use of secukinumab in patients with chronic infections;JEADV Clinical Practice;2024-01-20